Cash on Hand for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's latest reported cash and short-term investments is $22.05B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$22.05B
YoY change
-18.0%
5Y CAGR
-4.4%
Peak year (2016)
$41.91B
Latest annual
$20.10B
Cash on Hand history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Cash on Hand history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $20.10B | -18.0% | ||
| 2024 | $24.52B | +7.0% | ||
| 2023 | $22.93B | +2.9% | ||
| 2022 | $22.28B | -29.5% | ||
| 2021 | $31.61B | +25.5% | ||
| 2020 | $25.18B | +30.6% | ||
| 2019 | $19.29B | -2.0% | ||
| 2018 | $19.69B | +7.6% | ||
| 2017 | $18.30B | -56.3% | ||
| 2016 | $41.91B | +9.2% | ||
| 2015 | $38.38B | +16.0% | ||
| 2014 | $33.09B | +13.3% | ||
| 2013 | $29.21B | +38.5% | ||
| 2012 | $21.09B | -34.6% | ||
| 2011 | $32.26B | +16.6% | ||
| 2010 | $27.66B | +42.4% | ||
| 2009 | $19.43B | +51.7% | ||
| 2008 | $12.81B | +37.5% | ||
| 2007 | $9.31B | +128.1% | ||
| 2006 | $4.08B | -74.7% | ||
| 2005 | $16.14B | +25.3% | ||
| 2004 | $12.88B | +35.3% | ||
| 2003 | $9.52B | +27.4% | ||
| 2002 | $7.47B | -6.2% | ||
| 2001 | $7.97B | +18.0% | ||
| 2000 | $6.76B | +74.2% | ||
| 1999 | $3.88B | +39.4% | ||
| 1998 | $2.78B | +1.1% | ||
| 1997 | $2.75B | +36.9% | ||
| 1996 | $2.01B | +67.4% | ||
| 1995 | $1.20B | +88.8% | ||
| 1994 | $636.00M | +71.0% | ||
| 1993 | $372.00M | -50.1% | ||
| 1992 | $745.00M | +26.5% | ||
| 1991 | $589.00M | -28.7% | ||
| 1990 | $826.00M | +82.7% | ||
| 1989 | $452.00M | -31.5% | ||
| 1988 | $660.00M | -10.9% | ||
| 1987 | $741.00M | -22.2% | ||
| 1986 | $952.50M | +29.5% | ||
| 1985 | $735.60M | — |
Cash on Hand values are taken from Johnson & Johnson's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Johnson & Johnson (JNJ) cash and short-term investments is $20.10B – declined 18.0% year-over-year.
Johnson & Johnson cash and short-term investments has contracted on net over the period, with a -4.4% compound annual growth rate over 2020–2025 (5 years).
Johnson & Johnson cash and short-term investments plunged from $41.91B in 2016 to $20.10B in 2025, a 52.0% drawdown.
2016 marks the peak cash and short-term investments at $41.91B, with the historical low of $372.00M recorded in 1993.
Within Healthcare, Johnson & Johnson (JNJ) ranks 3rd among 8 peers we track. The peer median for cash and short-term investments is $9.62B.
Johnson & Johnson Cash on Hand by Year
Johnson & Johnson Cash on Hand 2025: $20.10B
Johnson & Johnson cash and short-term investments in 2025 was $20.10B, declined 18.0% below 2024.
Johnson & Johnson Cash on Hand 2024: $24.52B
Johnson & Johnson cash and short-term investments in 2024 was $24.52B, grew 7.0% from 2023.
Johnson & Johnson Cash on Hand 2023: $22.93B
Johnson & Johnson cash and short-term investments in 2023 was $22.93B, edged up 2.9% from 2022.
Johnson & Johnson Cash on Hand 2022: $22.28B
Johnson & Johnson cash and short-term investments in 2022 was $22.28B, declined 29.5% below 2021.
Johnson & Johnson Cash on Hand 2021: $31.61B
Johnson & Johnson cash and short-term investments in 2021 was $31.61B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — Cash on Hand
Companies in the same sector as Johnson & Johnson, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $10.11B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Johnson & Johnson's cash and short-term investments?
- Latest reported cash and short-term investments for Johnson & Johnson (JNJ) is $22.05B (period ending March 29, 2026).
How has Johnson & Johnson cash and short-term investments changed year-over-year?
- Johnson & Johnson (JNJ) cash and short-term investments changed -18.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson cash and short-term investments?
- Johnson & Johnson (JNJ) cash and short-term investments compound annual growth rate is -4.4% over the most recent 5 years available.
When did Johnson & Johnson cash and short-term investments hit its highest annual value?
- Johnson & Johnson cash and short-term investments reached its highest annual value of $41.91B in 2016.
What was Johnson & Johnson cash and short-term investments in 2024?
- Johnson & Johnson (JNJ) cash and short-term investments in 2024 was $24.52B.
What was Johnson & Johnson cash and short-term investments in 2025?
- Johnson & Johnson (JNJ) cash and short-term investments in 2025 was $20.10B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.